First results on the joint use of e2rebot and gradior to improve cognitive abilities

Abstract

In this paper we present the results of the first clinical trials conducted to evaluate the usefulness of the joint use of E2Rebot and Gradior to improve cognitive abilities in subjects with ABI, dementia and schizophrenia. E2Rebot is a cost-effective robotic platform for active assistance in the rehabilitation of patients suffering upper limb impairment as a consequence of ABI (Acquired Brain Injury). Gradior is a training and neuro-psychological rehabilitation software used in more than 450 centers at national and international level within the social and health sector. The results obtained in the quantitative study showed a general improvement in the average scores on cognitive tests although the differences are not statistically significant. This result encourages us to undertake a broader study with a greater number of subjects and longer in time.